Connect
MJA
MJA

    Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?

    Ross I Baker
    Med J Aust 2004; 180 (9): 436-437. || doi: 10.5694/j.1326-5377.2004.tb06015.x
    Published online: 3 May 2004

    Unravelling the uncertainties

    • Ross I Baker

    • Thrombosis and Haemophilia Unit, Royal Perth Hospital and University of Western Australia, Perth, WA.

    Correspondence: 

    Author
    remove_circle_outline Delete Author
    add_circle_outline Add Author
    Comment
    Do you have any competing interests to declare? *
    I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
    I/we agree to the Terms of use of the Medical Journal of Australia *
    Email me when people comment on this article
    Responses are now closed for this article.